ReActiv8 for Chronic Low Back Pain (PMCF)
ReActiv8-A
Investigation of the ReActiv8 Implantable Stimulation System for Chronic Low Back Pain
1 other identifier
interventional
96
3 countries
15
Brief Summary
The purpose of this Clinical Study is to investigate the effect of electrical stimulation for chronic low back pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2014
Longer than P75 for not_applicable
15 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 5, 2013
CompletedFirst Posted
Study publicly available on registry
November 15, 2013
CompletedStudy Start
First participant enrolled
February 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2024
CompletedMay 30, 2024
May 1, 2024
2.1 years
November 5, 2013
May 28, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
11 Point Numerical Rating Scale (NRS) for Low Back Pain
90 days
Number of subjects with Adverse Events
90 days, 12 months
Secondary Outcomes (1)
Oswestry Disability Index
90 days
Other Outcomes (1)
Subject Global Impression of Change
90 days
Study Arms (1)
ReActiv8 Implant
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years, ≤65 years
- Chronic Low Back Pain with a first occurrence \>90 days prior to enrolment, and the last relatively pain-free time \>90 days prior to enrolment.
- Continuing low back pain despite \>90 days of medical management
- Oswestry Disability Index score ≥25% and ≤60% at the time of enrolment
- Able to understand and sign the Informed Consent form.
- Ability to comply with the instructions for use and to operate the ReActiv8, and to comply with this Clinical Investigation Plan.
- Prior week average Low Back Pain NRS of ≥6.0 and ≤9.0 on a 11 point NRS scale (0-10) at the Baseline Visit
You may not qualify if:
- BMI \> 35
- Back Pain characteristics:
- Any surgical correction procedure for scoliosis at any time, or a current clinical diagnosis of scoliosis.
- Lumbar spine stenosis, as defined by an anterior-posterior diameter of the spinal canal of \<10mm in subjects with lower extremity pain
- Neurological deficit possibly associated with the back pain (e.g. foot drop).
- Back pain due to pelvic or visceral reasons (e.g.: endometriosis or fibroids) or infection (e.g.: post herpetic neuralgia).
- Back pain due to inflammation or damage to the spinal cord or adjacent structures (e.g. arachnoiditis or syringomyelia)
- Any current indication for back surgery according to local institutional guidelines, or has indication for back surgery but cannot undergo surgery for other reasons.
- Leg pain described as being worse than back pain, or radiculopathy (neuropathic pain) below the knee.
- Source of pain is the sacroiliac joint as determined by the Investigator.
- Drug use
- Any prior diagnosis of lumbar vertebral compression fracture, lumbar pars fracture, or lumbar annular tear with disc protrusion
- Planned surgery.
- Co-morbid chronic pain conditions
- Other clinical conditions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mainstay Medicallead
Study Sites (15)
Pain Medicine of South Australia
Adelaide, Australia
Hunter Clinical Research
Broadmeadow, Australia
Metro Spinal Clinic
Caulfield South, Australia
Precision, Brain, Spine and Pain Centre
Kew, Australia
Georgius Practice
Noosa, Australia
GZA Hospitals
Antwerp, Belgium
AZ Nikolaas
Sint-Niklaas, Belgium
Basildon & Thurrock University Hospitals
Basildon, United Kingdom
Southmead Hospital
Bristol, United Kingdom
Ipswich Hospital
Ipswich, United Kingdom
Seacroft Hospital
Leeds, United Kingdom
The Walton Centre
Liverpool, United Kingdom
St. Bartholomew's Hospital
London, United Kingdom
James Cook University Hospital
Middlesbrough, United Kingdom
Southampton University Hospitals
Southampton, United Kingdom
Related Publications (3)
Thomson S, Williams A, Vajramani G, Sharma M, Love-Jones S, Chawla R, Eldabe S. 5-year longitudinal follow-up of patients treated for chronic mechanical low back pain using restorative neurostimulation. Reg Anesth Pain Med. 2025 Aug 14:rapm-2025-106899. doi: 10.1136/rapm-2025-106899. Online ahead of print.
PMID: 40813075DERIVEDThomson S, Williams A, Vajramani G, Sharma M, Love-Jones S, Chawla R, Eldabe S. Restorative neurostimulation for chronic mechanical low back pain - Three year results from the United Kingdom post market clinical follow-up registry. Br J Pain. 2023 Oct;17(5):447-456. doi: 10.1177/20494637231181498. Epub 2023 Jun 6.
PMID: 38107760DERIVEDThomson S, Chawla R, Love-Jones S, Sharma M, Vajramani G, Williams A, Eldabe S; ReActiv8 PMCF Investigators. Restorative Neurostimulation for Chronic Mechanical Low Back Pain: Results from a Prospective Multi-centre Longitudinal Cohort. Pain Ther. 2021 Dec;10(2):1451-1465. doi: 10.1007/s40122-021-00307-3. Epub 2021 Sep 3.
PMID: 34478115DERIVED
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 5, 2013
First Posted
November 15, 2013
Study Start
February 1, 2014
Primary Completion
March 1, 2016
Study Completion
March 1, 2024
Last Updated
May 30, 2024
Record last verified: 2024-05